FRANKLIN LAKES, N.J.--(BUSINESS WIRE)--ReGen Biologics (OTC: RGBI) will exhibit the company’s products at the Arthroscopy Association of North America (AANA) meeting, being held this week in San Francisco.
Additionally, data from its CMI™ product clinical trial will be highlighted in two podium presentations and two “e-posters” as part of the scientific program offered to attending surgeons.
